IRCT20190725044331N1
Recruiting
Phase 3
Evaluation the Effect of N-acetylcysteine as a Neuroprotective in Traumatic Brain Injury Patients with Moderate to Severe Consciousness Level Admitted to Intensive Care Unit
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Traumatic Brain Injury (TBI).
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 28
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age range 18 – 65 year
- •Consciousness level 9\-12 based on Glasgow Coma Scale (GCS)
- •Transferred to intensive care unit less than 24 hours after trauma
Exclusion Criteria
- •Allergic reaction to N\-acetylcysteine
- •Stay in intensive care unit less than 72 hours
- •Pregnant patients
- •Associated spinal cord injury
- •History of autoimmune diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
The effect of N-acetylcysteine ??(NAC) on renal failure in Coronary surgeryPatients undergoing open heart surgery.IRCT20200823048491N1Esfahan University of Medical Sciences100
Recruiting
Phase 3
.Effect of N-acetylcysteeine on non-alcoholic fatty liver diseaseIRCT20201220049772N1Kashan University of Medical Sciences74
Recruiting
Phase 3
Effect of N-acetylcysteine in moderate to severe traumatic brain injuryIRCT20230815059150N1Iran University of Medical Sciences60
Not yet recruiting
Phase 3
The effect of N-Acetylcysteine on COVID-19IRCT20200509047364N3Bandare-abbas University of Medical Sciences40
Not yet recruiting
Phase 4
To study use of N- Acetylcysteine (NAC) as an adjunct therapy in the management of lower extremity vascular injuriesHealth Condition 1: S759- Injury of unspecified blood vesselat hip and thigh levelHealth Condition 2: S859- Injury of unspecified blood vesselat lower leg levelCTRI/2023/05/052257ALL INDIA INSTITUTE OF MEDICAL SCIENCES